Latest Affymetrix (Santa Clara, California) Microarray Offers New Users a Cost-effective and Easy-to-use Alternative for Gene-level Expression Profiling

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix Inc. (NASDAQ: AFFX) today announced the full commercial launch of the GeneChip® Human Gene 1.0 ST Array, the latest addition to its whole-transcript assay-based gene expression product family. The new microarray measures the overall expression of all transcripts derived from a gene, not just the 3’ end of a gene. As a result, the Human Gene 1.0 ST Array delivers a more complete and accurate view of a gene’s total transcription activity compared to traditional expression array designs.

MORE ON THIS TOPIC